FIELD: medicine.
SUBSTANCE: invention can be used for diagnostic analysis. Essence of invention consists in the fact that hardware system for diagnostic analyzes comprises support structure, inside which the first refrigerating container is located to contain at least one set of antibiotics (n), contained in ampoules or flasks and diluted with liquid medium to enable their distribution in liquid phase and testing them on a set of molecules, which can be selected by the operator, possibly also in a combination of concentrations (m), to enable to create a controlled antibiotic image, and determine a minimum inhibitory concentration for each of the selected antibiotics, an analytic region in which the microplates with a plurality of sockets or wells are placed, in which a portion of the primary sample is introduced, a sample extraction and delivery unit configured to extract a portion of the primary sample from the respective test tubes and deliver it to the wells of said microplates, temperature control area of microplates containing primary samples, and a robot head configured to interact with said extraction and delivery assembly with possibility of transferring primary samples taken from the test tubes in said microplates of the analytical region, and transferring the microplates to the temperature control region, and also configured to introduce into each of microplate wells a sample in which bacteria multiplication is identified, portion of one of said antibiotics (n) in liquid form is optionally at the discretion of the operator, sent as a function of the type of the identified type of bacteria.
EFFECT: possibility of performing fully automated tests for identifying samples with subsequent creation of a synergetic antibiotic image and improved technique for determining minimum inhibitory concentration.
12 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EXPRESS ANALYSIS IN VITRO OF ANTIBIOTIC SENSITIVITY OF BACTERIA AND FUNGI IN PATIENT | 2020 |
|
RU2735983C1 |
TEST SYSTEM FOR DETERMINING BACTERIAL FERMENTATIVE ACTIVITY BY AMMONIA | 2018 |
|
RU2715405C1 |
METHOD OF DETERMINING PRESENCE OF ANTHRAX PROTECTIVE ANTIGEN BASED ON IMMUNODETECTION, ASSOCIATED WITH POLYMERASE CHAIN REACTION | 2011 |
|
RU2470307C1 |
METHOD OF DETERMINING BOTULINUM NEUROTOXIN OF TYPE A BASED IMMUNODETECTION, COMBINED WITH POLYMERASE CHAIN REACTION | 2013 |
|
RU2549463C1 |
METHOD OF EVALUATING BACTERIAL LOAD OF URINE, PROSTATIC SECRETION, EJACULATE | 2010 |
|
RU2452773C1 |
STRAIN OF HCOV-19/RUSSIA/OMSK-202118-1707/2020 OF SARS-COV-2 CORONAVIRUS, IMMUNOSORBENT CONTAINING PURIFIED WHOLE VIRION ANTIGEN OBTAINED ON BASIS OF SPECIFIED STRAIN AND ISA TEST SYSTEM FOR DETECTING ANTIBODIES OF CLASSES M, G AND A TO SARS CORONAVIRUS-COV-2 USING SPECIFIED IMMUNOSORBENT | 2021 |
|
RU2752862C1 |
METHOD FOR DETERMINING SENSITIVITY OF BACTERIAL HEMOCULTURES TO ANTIBIOTICS | 2017 |
|
RU2666257C1 |
METHOD OF TREATING BACTERIAL RESPIRATORY INFECTIONS | 2019 |
|
RU2707505C1 |
METHOD OF DESTROYING AND PREVENTING FORMATION OF BACTERIAL BIOFILMS BY COMPLEX OF ANTIMICROBIAL PEPTIDES OF INSECTS | 2017 |
|
RU2664708C1 |
PREPARATION POSSESSING ANTIVIRAL AND IMMUNOCORRECTING EFFECT | 2004 |
|
RU2262946C1 |
Authors
Dates
2020-12-02—Published
2017-07-04—Filed